<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38965510</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Post-COVID syndrome prevalence: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1785</StartPage><MedlinePgn>1785</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1785</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-19264-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Since the Coronavirus disease 2019 (COVID-19) pandemic began, the number of&#xa0;individuals recovering from COVID-19 infection have increased. Post-COVID Syndrome, or PCS, which is defined as signs and symptoms that develop during or after infection in line with COVID-19, continue beyond 12&#xa0;weeks, and are not explained by an alternative diagnosis, has also gained attention. We systematically reviewed and determined the pooled prevalence estimate of PCS worldwide based on published literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Relevant articles from the Web of Science, Scopus, PubMed, Cochrane Library, and Ovid MEDLINE databases were screened using a Preferred Reporting Items for Systematic Reviews and Meta-Analyses-guided systematic search process. The included studies were in English, published from January 2020 to April 2024, had overall PCS prevalence as one of the outcomes studied, involved a human population with confirmed COVID-19 diagnosis and undergone assessment at 12&#xa0;weeks post-COVID infection or beyond. As the primary outcome measured, the pooled prevalence of PCS was estimated from a meta-analysis of the PCS prevalence data extracted from individual studies, which was conducted via the random-effects model. This study has been registered on PROSPERO (CRD42023435280).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty eight studies met the eligibility criteria and were included in this review. 16 were accepted for meta-analysis to estimate the pooled prevalence for PCS worldwide, which was 41.79% (95% confidence interval [CI] 39.70-43.88%, I<sup>2</sup>&#x2009;=&#x2009;51%, p&#x2009;=&#x2009;0.03). Based on different assessment or follow-up timepoints after acute COVID-19 infection, PCS prevalence estimated at&#x2009;&#x2265;&#x2009;3rd,&#x2009;&#x2265;&#x2009;6th, and&#x2009;&#x2265;&#x2009;12th months timepoints were each 45.06% (95% CI: 41.25-48.87%), 41.30% (95% CI: 34.37-48.24%), and 41.32% (95% CI: 39.27-43.37%), respectively. Sex-stratified PCS prevalence was estimated at 47.23% (95% CI: 44.03-50.42%) in male and 52.77% (95% CI: 49.58-55.97%) in female. Based on continental regions, pooled PCS prevalence was estimated at 46.28% (95% CI: 39.53%-53.03%) in Europe, 46.29% (95% CI: 35.82%-56.77%) in America, 49.79% (95% CI: 30.05%-69.54%) in Asia, and 42.41% (95% CI: 0.00%-90.06%) in Australia.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The prevalence estimates in this meta-analysis could be used in further comprehensive studies on PCS, which might enable the development of better PCS management plans to reduce the effect of PCS on population health and the related economic burden.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sk Abd Razak</LastName><ForeName>Ruhana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismail</LastName><ForeName>Aniza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia. aniza@ppukm.ukm.edu.my.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Public Health, Universitas Sumatera Utara, Jalan Universitas No. 21 Kampus USU, Medan, North Sumatra, 20155, Indonesia. aniza@ppukm.ukm.edu.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdul Aziz</LastName><ForeName>Aznida Firzah</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suddin</LastName><ForeName>Leny Suzana</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi (UiTM) MARA, Sungai Buloh, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azzeri</LastName><ForeName>Amirah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Primary Care, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia (USIM), Persiaran Ilmu, Putra Nilai, Nilai, Negeri Sembilan, 71800, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sha'ari</LastName><ForeName>Nur Insyirah</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38965510</ArticleId><ArticleId IdType="pmc">PMC11223303</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-19264-5</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-19264-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536&#x2013;44. doi: 10.1038/s41564-020-0695-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0695-z</ArticleId><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A. Wuhan novel coronavirus (COVID-19): why global control is challenging? Elsevier Public Heal Emerg Collect. 2020;179:A1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130979</ArticleId><ArticleId IdType="pubmed">32111295</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers J, Cheng HY, Lin HH, Barnard LT, Kvalsvig A, Wilson N, et al. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Heal &#x2013; West Pacific. 2020;4:44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577184</ArticleId><ArticleId IdType="pubmed">34013216</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO Director-General&#x2019;s Opening Remarks at the Media Briefing on COVID-19 - 11 March 2020. 2020.</Citation></Reference><Reference><Citation>Ministry of Health Malaysia . Post Covid-19 Management Protocol. 2021.</Citation></Reference><Reference><Citation>Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, et al. Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. 2021;93(12):6566&#x2013;6574. doi: 10.1002/jmv.27198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27198</ArticleId><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. Facing up to long COVID. Lancet. 2020;396(10266):1861. doi: 10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med . 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Felicity C, Elisa P. How and why patients made Long Covid. Soc Sci Med. 2021;268.:113426.2021;27(4):601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737&#x2013;54. https://doi.org/101080/2374423520211924397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Heal. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>NICE Guidelines, editor. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE Guidelines. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Alinaghi SAS, Bagheri AB, Razi A, Mojdeganlou P, Mojdeganlou H, Afsah AM, et al. Late complications of covid-19; an umbrella review on current systematic reviews. Arch Acad Emerg Med. 2023;11(1):e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10197916</ArticleId><ArticleId IdType="pubmed">37215236</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehraeen E, SeyedAlinaghi SA, Karimi A. The post-Omicron situation: The end of the pandemic or a bigger challenge? J Med Virol. 2022;94(8):3501&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35388514</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Baricich A, Patrucco F, Zeppegno P, Gramaglia C, Balbo PE, et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep . 2021;11(1):22666. doi: 10.1038/s41598-021-01215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01215-4</ArticleId><ArticleId IdType="pmc">PMC8608998</ArticleId><ArticleId IdType="pubmed">34811387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep [Internet]. 2021;11(1):13153. Available from:. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=med20&amp;NEWS=N&amp;AN=34162913</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;13. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S, Zahra H, Royer P-YY, Tipirdamaz C, Mercier J, Gendrin V, et al. Post-COVID-19 syndrome: Nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in nord franche-comt&#xe9; hospital, France. Microorganisms. 2021;9(8):1719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, et al. Symptom burden and immune dynamics 6 to 18 months following mild severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2): a case-control study. Clin Infect Dis. 2022;76:60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384725</ArticleId><ArticleId IdType="pubmed">35959897</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C, Zocchi C, Tassetti L, Silverii MV, Amato C, Livi L, et al. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med. 2022;97:36&#x2013;41. doi: 10.1016/j.ejim.2021.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmsdal G, Hanusson KD, Kristiansen MF, Foldbo BM, Danielsen ME, Steig B&#xc1;, et al. Long COVID in the long run - 23-month follow-up study of persistent symptoms. Open Forum Infect Dis. 2022;9(7). Available from:. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136307702&amp;doi=10.1093%2Fofid%2Fofac270&amp;partnerID=40&amp;md5=cbcb5cc2ee6b5652237920f2edfe20ea</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308378</ArticleId><ArticleId IdType="pubmed">35891696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, et al. Health status, persistent symptoms, and effort intolerance one year after acute COVID-19 infection. J Gen Intern Med. 2022;37(5):1218&#x2013;25. doi: 10.1007/s11606-021-07379-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07379-z</ArticleId><ArticleId IdType="pmc">PMC8786200</ArticleId><ArticleId IdType="pubmed">35075531</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DRT, Munipalli B, Logvinov II, Halkar MG, Mitri G , Dabrh AMA, et al. Perception, prevalence, and prediction of severe infection and post-acute sequelae of COVID-19. Am J Med Sci. 2022;363(4):295&#x2013;304. doi: 10.1016/j.amjms.2022.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8743283</ArticleId><ArticleId IdType="pubmed">35016849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Kaiser L, Soccal PM, et al. One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals. J Intern Med. 2022;292(1):103&#x2013;115. doi: 10.1111/joim.13482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13482</ArticleId><ArticleId IdType="pmc">PMC9115262</ArticleId><ArticleId IdType="pubmed">35555926</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Foldbo BM, Danielsen ME, Steig BA, et al. Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months&#x2019; follow-up. Int J Infect Dis. 2022;122:437&#x2013;441. doi: 10.1016/j.ijid.2022.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.031</ArticleId><ArticleId IdType="pmc">PMC9222150</ArticleId><ArticleId IdType="pubmed">35753603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, Lainez-Ramos-Bossini AJ, de Alba IGF, Ortiz-Gonzalez-Serna R, Serrano-Ortiz A, Fernandez-Martinez NF, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;20(1):92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisler A, Stirrup O, Pisarev H, Kalda R, Meister T, Suija K, et al. Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study. PLoS One. 2022;17(11):e0278057. doi: 10.1371/journal.pone.0278057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278057</ArticleId><ArticleId IdType="pmc">PMC9683565</ArticleId><ArticleId IdType="pubmed">36417409</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R, da Cunha TR, Dos Santos Silva LD, Ferreira CS, Silva CP, Ribeiro AP, et al. Persistent, new-onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non-hospitalized patients. BMC Infect Dis. 2022;22(1):133. doi: 10.1186/s12879-022-07065-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07065-3</ArticleId><ArticleId IdType="pmc">PMC8821794</ArticleId><ArticleId IdType="pubmed">35135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Ailshire JA, Crimmins EM. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci Rep. 2022;12(1):11647. doi: 10.1038/s41598-022-15727-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15727-0</ArticleId><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Babicki M, Ko&#x142;at D, Kapusta J, Ka&#x142;uzi&#x144;ska-Ko&#x142;at &#x17b;, Jankowski P, Mastalerz-Migas A, et al. Prevalence and assessment of risk factors among Polish adults with post-COVID-19 syndrome: a 12-month follow-up study. Polish Arch Intern Med. 2023;133(12):16512.</Citation><ArticleIdList><ArticleId IdType="pubmed">37338234</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Poletti F, Rostagno R, Moglia R, Cantone M, Esposito M, et al. Long-COVID syndrome in hospitalized patients after 2 years of follow-up. J Public Heal Emerg. 2023;7:4.</Citation></Reference><Reference><Citation>Daniel CL, Fillingim S, James J, Bassler J, Lee A. Long COVID prevalence and associated characteristics among a South Alabama population. Public Health. 2023;221:135&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">37451202</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima S, Ismail M, Ejaz T, Shah Z, Fatima S, Shahzaib M, et al. Association between long COVID and vaccination: A 12-month follow-up study in a low- to middle-income country. PLoS One. 2023;18(11):e0294780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10664948</ArticleId><ArticleId IdType="pubmed">37992084</ArticleId></ArticleIdList></Reference><Reference><Citation>Feter N, Caputo EL, Leite JS, Delpino FM, Silva LS da, Vieira YP, et al. Prevalence and factors associated with long COVID in adults from Southern Brazil: Findings from the PAMPA cohort. Cad Saude Publica. 2023;39(12):e00098023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715571</ArticleId><ArticleId IdType="pubmed">38088735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar P, Dias M, Parreira I, Gon&#xe7;alves HD, Parlato F, Maione V, et al. Predictors of long-COVID-19 and its impact on quality of life: longitudinal analysis at 3, 6 and 9 months after discharge from a Portuguese centre. In: Acta Medica Portuguesa. 2023;36(10):647&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">36827994</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Mills NL, Winter AJ, Black C, et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14(1):7892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10689486</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua MJ, Gonakoti S, Shariff R, Corpuz C, Acosta RAH, Chang H, et al. Prevalence and Characteristics of Long COVID 7&#x2013;12 Months After Hospitalization Among Patients From an Urban Safety-Net Hospital: A Pilot Study. AJPM Focus. 2023;2(3):100091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10036151</ArticleId><ArticleId IdType="pubmed">37131536</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayasekera MMPT, De Silva NL, Edirisinghe EMDT, Samarawickrama T, Sirimanna SWDRC, Govindapala BGDS, et al. A prospective cohort study on post COVID syndrome from a tertiary care centre in Sri Lanka. Sci Rep. 2023;13(1):15569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511420</ArticleId><ArticleId IdType="pubmed">37730947</ArticleId></ArticleIdList></Reference><Reference><Citation>Jogdand MS, Bhondwe MR, Jogdand KS, Yerpude PN, Tathe GR, Wadiyar SS. Prevalence and Determinants of Long COVID among the COVID-19 Survivors: A Cross-sectional Study from A Rural Area of Maharashtra. Indian J Community Heal. 2023;35(2):193&#x2013;8.</Citation></Reference><Reference><Citation>Khanafer N, Henaff L, Bennia S, Termoz A, Chapurlat R, Escuret V, et al. Factors Associated with Long COVID-19 in a French Multicentric Prospective Cohort Study. Int J Environ Res Public Health. 2023;20(17):6678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10488030</ArticleId><ArticleId IdType="pubmed">37681818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, Kim SW. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci Rep. 2023;13(1):11207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnadath I, Harkisoen S, Gopie F, van der Hilst K, Hollum M, Woittiez L, et al. Prevalence of persistent symptoms after having COVID-19 in a cohort in Suriname. Rev Panam Salud Publica/Pan Am J Public Heal. 2023;47:e79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10184584</ArticleId><ArticleId IdType="pubmed">37197595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapa J, Rosa D, Mendes JPL, Deusdar&#xe1; R, Romero GAS. Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge. Int J Environ Res Public Health. 2023;20(1):848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9820092</ArticleId><ArticleId IdType="pubmed">36613170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Ayala MC, Proa&#xf1;os NJ, Cala-Duran J, Lora-Mantilla AJ, C&#xe1;ceres-Ram&#xed;rez C, Villabona-Fl&#xf3;rez SJ, et al. Factors associated with long COVID syndrome in a Colombian cohort. Front Med. 2023;10:1325616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10767647</ArticleId><ArticleId IdType="pubmed">38188329</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoy JCC, Ford J, Yu H, Gottlieb M, Morse D, Santangelo M, et al. Prevalence of Symptoms &#x2264;12 Months After Acute Illness, by COVID-19 Testing Status Among Adults &#x2014; United States, December 2020&#x2013;March 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):859&#x2013;65. doi: 10.15585/mmwr.mm7232a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a2</ArticleId><ArticleId IdType="pmc">PMC10415002</ArticleId><ArticleId IdType="pubmed">37561663</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, De Martino M, Palese A, Chiappinotto S, Fonda F, Gerussi V, et al. Post-COVID-19 syndrome 2 years after the first wave: the role of humoral response, vaccination and reinfection. Open Forum Infect Dis. 2023;10(7):ofad364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10372856</ArticleId><ArticleId IdType="pubmed">37520419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Onieva A, Vallejo Basurte C, Fern&#xe1;ndez Bersab&#xe9; A, Camacho Cerro L, Valverde Basc&#xf3;n B, Muriel Sanjuan N, et al. Clinical characterization of the persistent COVID-19 symptoms: a descriptive observational study in primary care. J Prim Care Community Heal. 2023;14:21501319231208283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10638863</ArticleId><ArticleId IdType="pubmed">37947104</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva KM, Freitas DCA, Medeiros SS, Miranda LVA, Carmo JBM, Silva RG, et al. Prevalence and predictors of COVID-19 long-term symptoms: a cohort study from the Amazon Basin. Am J Trop Med Hyg. 2023;109(2):466&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10397456</ArticleId><ArticleId IdType="pubmed">37364863</ArticleId></ArticleIdList></Reference><Reference><Citation>Talhari C, Criado PR, Castro CCS, Ianhez M, Ramos PM, Miot HA. Prevalence of and risk factors for post-COVID: Results from a survey of 6,958 patients from Brazil. An Acad Bras Cienc. 2023;95(1):e20220143.</Citation><ArticleIdList><ArticleId IdType="pubmed">36995792</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TK, Truong SN, Thanh LT, Gia NLH, Trung HP, Dinh BT. Post-COVID condition: a survey of patients recovered from COVID-19 in Central Vietnam. J Infect Dev Ctries. 2023;17(9):1213&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">37824353</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaden T, Mutubuki EN, de Bruijn S, Leung KY, Knoop H, Slootweg J, et al. Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands. J Infect Dis. 2023;227(9):1059&#x2013;1067. doi: 10.1093/infdis/jiac474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac474</ArticleId><ArticleId IdType="pubmed">36477364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C, Forsberg G, Divanoglou A, &#xd6;stholm Balkhed &#xc5;, Niward K, Berg S, et al. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. Lancet Reg Heal - Eur. 2023;28:100595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9951394</ArticleId><ArticleId IdType="pubmed">36855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MCS, Huang J, Wong YY, Wong GLH, Yip TCF, Chan RNY, et al. Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study. JMIR Public Heal Surveill. 2023;9:e42315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="pubmed">36645453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla OY, Ferm&#xed;n-Mart&#xed;nez CA, Ram&#xed;rez-Garc&#xed;a D, Vargas-V&#xe1;zquez A, Fern&#xe1;ndez-Chirino L, Basile-Alvarez MR, et al. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data. Lancet Reg Heal - Am. 2024;30:100688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10847769</ArticleId><ArticleId IdType="pubmed">38327277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwaikolo C, Sackie-Wapoe Y, Badio M, Glidden D V., Lindan C, Martin J. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia. Int J Epidemiol. 2024;53(1):dyad167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10859153</ArticleId><ArticleId IdType="pubmed">38052015</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangnin R, Ritruangroj W, Kittisupkajorn S, Sukeiam P, Inchai J, Maneeton B, et al. Long-COVID prevalence and its association with health outcomes in the post-vaccine and antiviral-availability era. J Clin Med. 2024;13(5):1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10931928</ArticleId><ArticleId IdType="pubmed">38592016</ArticleId></ArticleIdList></Reference><Reference><Citation>Keng Tok PS, Kang KY, Ng SW, Rahman NA, Syahmi MA, Pathmanathan MD, et al. Post COVID-19 condition among adults in Malaysia following the omicron wave: a prospective cohort study. PLoS One. 2024;19(1):e0296488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10769055</ArticleId><ArticleId IdType="pubmed">38181017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen KH, Bao Y, Mortazavi J, Allen JD, Chocano-Bedoya PO, Corlin L. Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022. Vaccines. 2024;12(1):99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10820629</ArticleId><ArticleId IdType="pubmed">38250912</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro M, Gothi D, Anand S, Priyadarshini DPDK, Ojha UC, Pal RS, et al. Follow-up study of COVID-19 sequelae (FOSCO study). Lung India. 2024;41(2):103&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10959308</ArticleId><ArticleId IdType="pubmed">38700403</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon D, Slama D, Linard F, Dumesges N, Le Baut V, Hakim F, et al. Patients with Long COVID continue to experience significant symptoms at 12 months and factors associated with improvement: A prospective cohort study in France (PERSICOR). Int J Infect Dis. 2024;140:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">38141960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S, Pryor AJG, Melville GW, Fischer O, Hewitt L, Davis KJ. The lingering symptoms of post-COVID-19 condition (long-COVID): a prospective cohort study. Intern Med J. 2024;54(2):224&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">38008902</ArticleId></ArticleIdList></Reference><Reference><Citation>Woldegiorgis M, Cadby G, Ngeh S, Korda RJ, Armstrong PK, Maticevic J, et al. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey. Med J Aust. 2024;220(6):323&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">38508863</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">18832388</ArticleId></ArticleIdList></Reference><Reference><Citation>Melsen WG, Bootsma MCJ, Rovers MM, Bonten MJM. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014;20(2):123&#x2013;9. doi: 10.1111/1469-0691.12494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12494</ArticleId><ArticleId IdType="pubmed">24320992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JL, Liu JL. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol. 2000;53(5):477&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">10812319</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy FM, Hairi NN, Lim ERJ, Bulgiba A. Long COVID and its associated factors among COVID survivors in the community from a middle-income country-An online cross-sectional study. PLoS One. 2022;17(8):e0273364. doi: 10.1371/journal.pone.0273364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273364</ArticleId><ArticleId IdType="pmc">PMC9426885</ArticleId><ArticleId IdType="pubmed">36040960</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, Das K, Venkateshan M. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One . 2022;17(12):e0278825. doi: 10.1371/journal.pone.0278825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabali MA, Alsabban AS, Bahakeem LM, Zwawy MA, Bagasi AT, Bagasi HT, et al. Persistent Symptoms Post-COVID-19: An Observational Study at King Abdulaziz Medical City, Jeddah, Saudi Arabia. CUREUS J Med Sci. 2022;14(4):e24343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9123896</ArticleId><ArticleId IdType="pubmed">35607525</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkwai HM, Khalifa AM, Ahmed AM, Alnajib AM, Alshammari KA, Alrashidi MM, et al. Persistence of COVID-19 symptoms beyond 3 months and the delayed return to the usual state of health in Saudi Arabia: A cross-sectional study. Sage Open Med. 2022;10:20503121221129918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9548451</ArticleId><ArticleId IdType="pubmed">36226231</ArticleId></ArticleIdList></Reference><Reference><Citation>Baris SA, Toprak OB, Cetinkaya PD, Fakili F, Kokturk N, Kul S, et al. The predictors of long-COVID in the cohort of Turkish Thoracic Society-TURCOVID multicenter registry: One year follow-up results. Asian Pac J Trop Med. 2022;15(9):400&#x2013;9. doi: 10.4103/1995-7645.354422.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1995-7645.354422</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bitna Ha, Kim SW, Chang HH, Kwon KT, Bae S, et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22(1):1&#x2013;12. doi: 10.1186/s12879-022-07062-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoto W, Yamada K, Kawai R, Imai T, Kawamoto K, Uji M, et al. A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID. Sci Rep. 2022;12(1):22413. doi: 10.1038/s41598-022-25398-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25398-6</ArticleId><ArticleId IdType="pmc">PMC9793373</ArticleId><ArticleId IdType="pubmed">36575200</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, de la Cerda MLR, et al. Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Ther Adv Infect Dis. 2022;9:20499361211069264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada-Codecido J, Chan AK, Andany N, Lam PW, Nguyen M, Pinto R, et al. Prevalence and predictors of persistent post-COVID-19 symptoms. JAMMI . 2022;7(3):208&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9629726</ArticleId><ArticleId IdType="pubmed">36337595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med . 2021;27(4):626&#x2013;31. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Krausslich HG, Brockmann SO, Gopel S, Kindle G, et al. Post-acute sequelae of covid-19 six to 12 months after infection: population based study. August D Blankenhorn B, Bopp-Haas U, Bunk S, Deibert P, Dietz A, Friedmann-Bette B, Giesen R, Gotz V, Grote S, Gruner B, Junginger A, Kappert O, Kirsten J, Kuhn A, Malek NP, Muller B, Niess A, Pfau S, Piechotowski I, Rieg S, Rottele S, Schellenberg J, Sc BC, Group EP 1 S, editors. BMJ. 2022;379:e071050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostev K, Smith L, Koyanagi A, Konrad M, Jacob L. Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19. Pediatr Res. 2022;95:182&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107066</ArticleId><ArticleId IdType="pubmed">35568733</ArticleId></ArticleIdList></Reference><Reference><Citation>Forster C, Colombo MG, Wetzel AJ, Martus PJ, Joos S. Persisting Symptoms After COVID-19. Dtsch Arztebl Int. 2022;119(10):167-+.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9215272</ArticleId><ArticleId IdType="pubmed">35236547</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Capriotti V, D&#x2019;Alessandro A, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19) Int Forum Allergy Rhinol . 2021;11(12):1685&#x2013;8. doi: 10.1002/alr.22832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Zhang L, Elb&#xe9;ji A, Wilmes P, Oustric P, Staub T, et al. Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect Dis [Internet]. 2022;9(8). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141512873&amp;doi=10.1093%2Fofid%2Fofac397&amp;partnerID=40&amp;md5=9e13b2fa20e3f1ebd3deac40523cbd4d.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenegro P, Moral I, Puy A, Cordero E, Chantada N, Cuixart L, et al. Prevalence of Post COVID-19 Condition in Primary Care: A Cross Sectional Study. Int J Environ Res Public Health. 2022;19(3):1836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8834857</ArticleId><ArticleId IdType="pubmed">35162857</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. group C-A research, editor. J Infect. 2021;82(3):378&#x2013;83. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Hartman TC, Rosmalen JGM. Initiative LCR. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS One. 2021;16(7):e0254523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Abdeeva E Antsiferova E, Artigas E, Bairashevskaia A, Belkina A, Bezrukov V, Bordyugov S, Bratukhina M, Chen J, Deunezhewa S, Elifkhanova K, Ezhova A, Filippova Y, Frolova A, Ganieva J, Gorina A, Kalan Y, Kirillov B, Korgunova M, Krupina A, Kuznetsova A, AN, Team SSR, editors. Clin Exp Allergy . 2021;51(9):1107&#x2013;20. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentr&#xe9; F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021;27(7):1041.e1&#x2013;1041.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Reports. 2021;11(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis . 2022;226(9):1593&#x2013;607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Udeh R, Yon DK, Lee SW, Dolja-Gore X, McEVoy M, et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J Med Virol. 2023;95(6):e28852.</Citation><ArticleIdList><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz J V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. The Lancet Infectious Diseases. 2022;22(4):e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med J R Coll Physicians London. 2021;21(1):e68&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;66. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S, O&#x2019;Connor R, Sivan M. Long COVID and chronic COVID syndromes. J Med Virol. 2021;93(3):1242&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675759</ArticleId><ArticleId IdType="pubmed">33034893</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ML, Catalfamo CJ, Farland L V., Ernst KC, Jacobs ET, Klimentidis YC, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 2021;16(8):e0254347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. Prevalence and risk factors of Post-COVID-19 Condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in moscow (Stop COVID). SSRN Electron J. 2022;20:244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, Ross D, Halpin S, Simms A, et al. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community. 2021. 10.1177/21501327211010994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Loeches I, Motos A, Men&#xe9;ndez R, Gabarr&#xfa;s A, Gonz&#xe1;lez J, Fern&#xe1;ndez-Barat L, et al. ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome. J Clin Med. 2022;11(1):224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8746263</ArticleId><ArticleId IdType="pubmed">35011967</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. -month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex. J Med Virol. 2020;92(10):2050&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267228</ArticleId><ArticleId IdType="pubmed">32383183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes. 2012;36(8):1072&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3270113</ArticleId><ArticleId IdType="pubmed">22024641</ArticleId></ArticleIdList></Reference><Reference><Citation>Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33(36):4422&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547886</ArticleId><ArticleId IdType="pubmed">26163925</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores S, Brown A, Adeoye S, Jason LA, Evans M. Examining the impact of obesity on individuals with chronic fatigue syndrome. Work Heal Saf. 2013;61(7):299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3899694</ArticleId><ArticleId IdType="pubmed">23799656</ArticleId></ArticleIdList></Reference><Reference><Citation>McElfish PA, Purvis R, James LP, Willis DE, Andersen JA. Perceived barriers to covid-19 testing. Int J Environ Res Public Health. 2021;18(5):2278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7956381</ArticleId><ArticleId IdType="pubmed">33668958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann L, Bhattacharya S, Purkayastha S, Kundu R, Bhaduri R, Ghosh P, et al. SARS-CoV-2 infection fatality rates in india: systematic review, meta-analysis and model-based estimation. Stud Microeconomics. 2021;9(2):137&#x2013;79.</Citation></Reference><Reference><Citation>Rahmandad H, Lim TY, Sterman J. Behavioral dynamics of COVID-19: estimating underreporting, multiple waves, and adherence fatigue across 92 nations. Syst Dyn Rev. 2021;37(1):5&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250772</ArticleId><ArticleId IdType="pubmed">34230767</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller SA, Isaaka L, Mumm R, Scheidt-Nave C, Heldt K, Schuster A, et al. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review. Lancet Glob Heal. 2023;11(11):e1713&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">37858583</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>